Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Laryngeal dystonia: A series with botulinum toxin therapy
Andrew Blitzer
, Mitchell F. Brin
Research output
:
Contribution to journal
›
Article
›
peer-review
185
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Laryngeal dystonia: A series with botulinum toxin therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Dystonia
100%
Laryngeal Dystonia
100%
Botulinum Toxin Therapy
100%
Spasm
66%
Botulinum Neurotoxin (BoNT)
66%
Laryngeal muscles
66%
Adductor
66%
Adverse Effects
33%
Clinically Significant
33%
Respiration
33%
Treatment Choice
33%
Dystonic
33%
Recurrent Laryngeal Nerve
33%
Dysphonia
33%
Normal Function
33%
Phonatory
33%
Spasmodic Dysphonia
33%
Whispering Dysphonia
33%
Sustained Improvement
33%
Phonation
33%
Nerve Section
33%
Abductor
33%
Paradoxical Vocal Fold Motion
33%
Abductor muscle
33%
Speech Patterns
33%
Adductor Spasm
33%
Whispering
33%
Nursing and Health Professions
Spasmodic dysphonia
100%
Clostridium Botulinum Type A
100%
Dystonia
75%
Muscle Spasm
75%
Muscle
75%
Dysphonia
50%
Adverse Event
25%
Syndrome
25%
Respiratory Failure
25%
Logopedics
25%
Nerve Transection
25%